Recordati
Tracked across 2 events · 12 articles · First seen Jun 25, 2026 · Last active Jul 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Recordati is the parent company; the launch expands its private markets capabilities and strengthens its ability to serve a broader international investor base.
Jul 08, 2026 · 6 articles
Business
Impact: Recordati obtained exclusive rights to develop and commercialize zilganersen outside the U.S., expanding its rare diseases portfolio with a potentially transformative therapy for Alexander disease.
Jun 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Recordati live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard